In this handout image released by the Generalitat de Catalunya (Catalan regional government) a first batch of the Pfizer-BioNTech Covid-19 vaccine is unpacked at the Banc de Sang i Teixits (tissues and boold bank) in Barcelona on December 27, 2020. - Less than a week after the green light for the Pfizer-BioNtech vaccine, several European Union states including Italy, Spain and France, all severely affected by the pandemic, began their vaccination campaigns today against the coronavirus, following in the footsteps of many other countries. (Photo by Handout / various sources / AFP) / RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO /GENERALITAT DE CATALUNYA" - NO MARKETING - NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS

La dose aggiuntiva del vaccino anti Covid-19 protegge per l’82% dalla malattia severa.

Lo indica l’Istituto Superiore di Sanità (Iss) nel suo rapporto settimanale su “Covid-19, sorveglianza, impatto delle infezioni ed efficacia vaccinale”.

A cura di Silvia Camerini – Foto Imagoeconomica 

Redazione IL POPOLANO

La Cesenate

LASCIA UN COMMENTO

Per favore inserisci il tuo commento!
Per favore inserisci il tuo nome qui